carbostyril has been researched along with Adenoma Sebaceum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, AJ; Ben-Ari, Y; Bordey, A; Buhler, E; Bulteau, C; Burnashev, N; Cardoso, C; Delalande, O; Dorfmuller, G; Dulac, O; Gataullina, S; Goriounova, NA; Lozovaya, N; Milh, M; Minlebaev, M; Pallesi-Pocachard, E; Represa, A; Scavarda, D; Shityakov, S; Tsintsadze, T; Tsintsadze, V; Watrin, F | 1 |
1 other study(ies) available for carbostyril and Adenoma Sebaceum
Article | Year |
---|---|
Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.
Topics: Action Potentials; Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Epilepsy; Gene Expression Regulation; Heterozygote; Humans; Male; Mice; Mice, Transgenic; Microtomy; Neocortex; Patch-Clamp Techniques; Pyrazoles; Quinolones; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tissue Culture Techniques; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2014 |